MICROBIAL PATHOGENESIS, published by Academic Press Ltd - Elsevier Science Ltd, is a prominent journal in the fields of Infectious Diseases and Microbiology, with a notable impact factor and classified in the Q2 quartile for both categories as of 2023. Since its inception in 1986, this journal has provided a platform for the dissemination of cutting-edge research that enhances our understanding of microbial infections and their implications in health and disease. The journal is indexed in Scopus, ranking #80 among 344 in Infectious Diseases and #57 among 182 in Microbiology, underscoring its significant contribution to the scientific community. Although it operates under a traditional subscription model, the content is vital for researchers, professionals, and students focused on the dynamics of microbial pathogenesis and the development of innovative therapeutic strategies. The journal's comprehensive scope aims to foster advancements in this critical area of study, bridging the gap between laboratory research and clinical applications.

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, published by Elsevier Science Inc, is a leading journal in the fields of Infectious Diseases, Microbiology, and Medicine. Since its inception in 1983, this esteemed journal has consistently provided a platform for original research and comprehensive reviews that advance the understanding of diagnostic microbiology and its implications for infectious diseases. With an impressive impact factor placing it in the Q2 category in multiple relevant fields as of 2023, it stands out with Scopus rankings reinforcing its significance in academia, ranking #136 out of 344 in Infectious Diseases and #64 out of 140 in Medical Microbiology. This journal is essential for researchers, healthcare professionals, and students who seek to stay abreast of the latest developments and trends in infectious diagnostics. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE is committed to fostering excellence in research quality and academic rigor, ensuring accessibility to vital knowledge for addressing some of the most pressing health challenges of our time.

Nature Microbiology is a premier journal published by NATURE PORTFOLIO that has firmly established itself within the realms of microbiological research since its inception in 2016. Based in the United Kingdom, this prestigious journal specializes in the intricacies of applied microbiology, cell biology, genetics, immunology, and medical microbiology, making it a cornerstone for academics and professionals alike. With an impressive Scopus ranking placing it in the top tier across various relevant categories—such as rank #3 in Genetics and #2 in Applied Microbiology—it underscores the journal’s commitment to high-quality, impactful research. Although it operates under a subscription model, Nature Microbiology's broad Open Access policy facilitates greater dissemination and visibility for its authors. The journal's objectives are centered around publishing cutting-edge advancements that enhance our understanding of microbial life, its interactions, and applications in health and disease. As a Q1 journal across multiple disciplines, it holds immense significance for researchers, professionals, and students enthusiastic about the latest innovations and breakthroughs in microbiology.

Surgical Infections, published by MARY ANN LIEBERT, INC, is an esteemed journal dedicated to advancing the understanding and management of infections associated with surgical procedures. With an ISSN of 1096-2964 and an E-ISSN of 1557-8674, this journal has emerged as a vital resource within the fields of Infectious Diseases, Surgery, and Microbiology. Over the years, it has established a notable presence, achieving a 2023 Q2 ranking in Infectious Diseases and Surgery, as well as a Q3 ranking in Microbiology. The journal holds an impressive position at 74th percentile in Surgery according to Scopus, making it a reliable platform for disseminating current research and clinical practices. Surgical Infections aims to provide an interdisciplinary forum for both seasoned professionals and academics, encouraging the exploration of novel therapeutic approaches, prevention strategies, and case studies that address the complexities of surgical-related infections. As the field continues to evolve, this journal remains committed to fostering innovative research that enhances clinical outcomes and patient safety.

TRENDS IN MICROBIOLOGY is a premier academic journal published by CELL PRESS, renowned for its high-impact research contributions in the fields of microbiology, infectious diseases, medical microbiology, and virology. With an impressive impact factor and a notable Scopus ranking—placing it in the top tiers of its categories, including a remarkable Q1 status in multiple disciplines—this journal is essential for researchers, professionals, and students aiming to stay at the forefront of innovative microbial research and ongoing advancements in pathogen biology. Since its inception in 1993, TRENDS IN MICROBIOLOGY has provided a platform for thought-provoking reviews and critical insights, fostering discussions that shape the future of the microbiological sciences. Based in the United Kingdom, TRENDS IN MICROBIOLOGY continues to lead the way in disseminating vital knowledge within the global scientific community.

Medical Microbiology and Immunology is a renowned journal published by Springer, serving as a pivotal resource in the fields of microbiology and immunology. Established in 1971 and continuing its legacy through 2024, this journal features cutting-edge research and reviews that address critical advancements and challenges within these dynamic fields. With an impressive impact factor and a robust ranking, including Q1 categories in both Microbiology (medical) and Immunology, it stands at the forefront of scholarly communication, ranking 21st out of 140 in the realm of Medical Microbiology. Researchers and professionals are encouraged to explore a variety of studies that delve into the interactions between microorganisms and the immune system, making it an essential resource for anyone fascinated by these interconnected realms of health sciences. Although not open access, the journal is widely accessible through institutional libraries, ensuring that significant findings reach a global audience. The University of New York Plaza serves as its operational hub in the USA, reinforcing its international influence and dedication to advancing knowledge in microbiology and immunology.

Welcome to the International Journal of Medical Microbiology, a leading publication in the field of microbiological research and infectious diseases, offered by Elsevier GmbH. Established in 2000, this esteemed journal provides a scholarly platform for the presentation of high-quality research, reviews, and innovations that bridge medical microbiology and clinical applications. With an impressive impact factor positioning it within the Q1 category across multiple disciplines, including Infectious Diseases, Microbiology, and Medicine, the journal is recognized for its rigorous peer-review process and significant contributions to advancing our understanding of microbial pathogenesis, diagnostics, and therapeutics. The International Journal of Medical Microbiology is committed to open access, promoting the dissemination of knowledge and accessibility for researchers, professionals, and students worldwide. Based in Munich, Germany, the journal continues to play a vital role in the global scientific community, fostering collaborations and inspiring future innovations in the fight against infectious diseases.

MIKROBIYOLOJI BULTENI, with ISSN 0374-9096, is a prestigious academic journal published by the ANKARA MICROBIOLOGY SOC, located in Ankara, Turkey. Established in 1973, this journal has been a vital conduit for disseminating research in the fields of Immunology, Microbiology, and Infectious Diseases, garnering a reputation as a significant contributor to the scientific community. The journal is currently ranked in the Q3 category within Immunology and Microbiology (miscellaneous), and Infectious Diseases, indicating its impactful presence amidst contemporary research. With access options that may be restricted, MIKROBIYOLOJI BULTENI actively welcomes submissions that advance the understanding of critical microbiological principles and practices, thereby supporting both national and international research efforts. Researchers, professionals, and students are encouraged to explore the latest findings shared in this journal, as it continually shapes the landscape of microbiology and infectious disease studies through its comprehensive and rigorous peer-reviewed publications.

Microbiology Spectrum is a prominent peer-reviewed journal published by the American Society for Microbiology, dedicated to advancing the field of microbiology through the dissemination of high-quality research. Since its inception in 2013 and continuing until 2024, the journal has established a strong presence in key domains such as microbiology, immunology, cell biology, and ecology, achieving impressive quartile rankings including Q1 in Infectious Diseases and Q1 in Immunology and Microbiology as of 2023. With an emphasis on open access to its scholarly content, Microbiology Spectrum aims to foster collaboration and knowledge sharing among researchers, professionals, and students alike. The journal's scope encompasses a diverse range of topics pertinent to the field, making it an essential resource for anyone involved in microbiological research and its applications. Researchers looking to publish their findings in a respected journal will find Microbiology Spectrum's robust impact factor and Scopus rankings serve as testament to its significance and influence within the academic community.

Current Research in Microbial Sciences is a distinguished peer-reviewed journal published by Elsevier, focusing on the dynamic and rapidly advancing fields of microbiology and infectious diseases. With an ISSN of 2666-5174, this journal has established itself as an essential resource for researchers, professionals, and students alike, offering the latest findings and insights from 2020 to 2024. The journal holds a significant position in the academic landscape, achieving a Q2 ranking across multiple categories, including Immunology and Microbiology, Infectious Diseases, and Medical Microbiology, demonstrating its impact in these critical areas of study. With impressive Scopus rankings—such as being placed in the 94th percentile for Immunology and Microbiology—current research is well-supported by a thriving scientific community. Although the journal is not open access, it serves as a vital platform for disseminating high-quality research and fostering collaboration within the microbial sciences. Engaging with this journal enables professionals and researchers to stay abreast of innovations and contribute to the collective body of knowledge that shapes our understanding of microbial interactions and infectious diseases.